Sibaja JJD

Idioma: Español
Referencias bibliográficas: 18
Paginas: 185-188
Archivo PDF: 173.42 Kb.

RESUMEN

La terapia de mantenimiento y alivio con budesonida/formoterol en un único inhalador constituye un concepto reciente y novedoso para alcanzar el control en pacientes asmáticos no controlados con el uso de esteroides inhalados en combinación con β2 agonistas de acción prolongada como mantenimiento y uso de β2 agonistas de acción corta a demanda como rescate.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Bai TR, Vonk JM, Postma DS, et al. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J 2007 Sep; 30 (3): 452-6].

2. Bousquet J, Boulet LP, Peters MJ, et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respir Med. Epub 2007 Oct 1

3. British Thoracic Society. British guideline on the management of asthma: a national clinical guideline [online]. Disponible en URL: http://www.sign. ac.uk/guidelines/fulltext/101/index.html [Accesado Junio 14, 2012]

4. Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. Drugs 1992; 44 (3): 375-40

5. Cheer SM, Scott LJ. Formoterol: a review of its use in chronic asthma. Am J Respir Med 2002; 1 (4): 285-300

6. Faulds D, Hollingshead LM, Goa KL. Formoterol: a review of its pharmacological properties and therapeutic potential reversible obstructive airways disease. Drugs 1991 Jul; 42 (1):115-37

7. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention [online]. Disponible en URL: http://www.ginasthma.com [Accesado Junio 14, 2012].

8. Hospenthal MAC, Peters JI. Longacting β2-agonists in the management of asthma exacerbations. Curr Opin Pulm Med 2005 Jan; 11 (1): 69-73

9. Hvizdos KM, Jarvis B. Budesonide inhalation suspension: a. review of its use in infants, children and adults with inflammatory respiratory disorders. Drugs 2000 Nov; 60 (5): 1141-78

10. Kuna P, Peters MJ, Manjra AI, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract 2007 May; 61 (5): 725-36

11. National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. Full report 2007 [online]. Disponible en URL: http:// www.nhlbi.nih.gov/guidelines/asthma/ asthgdln.htm [Accesado Junio 14, 2012].

12. O’Byrne PM, Barnes PJ, Rodriguez- Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001 Oct 15; 164 (8): 1392-7

13. O’Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005 Jan 15; 171 (2): 129-36

14. Rabe KF, Atienza T, Magyar P, et al. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 2006 Aug 26; 368 (9537): 744-53

15. Rabe KF, Pizzichini E, St¨allberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006 Feb; 129 (2): 246-56

16. Scicchitano R, Aalbers R, Ukena D, et al. Efficacy and safety of budesonide/ formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004 Sep; 20 (9): 1403-18

17. Thorsson L, Edsbacker S, Conradson T-B. Lung deposition of inhaled budesonide from Turbuhaler® is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J 1994; 7: 1839-44

18. Vogelmeier C, D’Urzo A, Pauwels R, et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Resp J 2005 Nov; 26 (5): 819-28